A phase II study of additional four-week chemotherapy with capecitabine during the resting periods after six-week neoadjuvant chemoradiotherapy in patients with locally advanced rectal cancer

Category Primary study
JournalAnnals of Coloproctology
Year 2013
This article has no abstract
Epistemonikos ID: f002c3dd8745980f3d9b9a9f3f2213f1a02d7e69
First added on: Feb 05, 2025